New insights on inflammation in chronic kidney disease–genetic and non-genetic factors
- 1 July 2006
- journal article
- review article
- Published by JLE in Nephrologie & Therapeutique
- Vol. 2 (3) , 111-119
Abstract
Cardiovascular disease (CVD) remains the major cause of morbidity and mortality in chronic kidney disease (CKD). As traditional risk factors cannot alone explain the unacceptable high prevalence and incidence of CVD in this population, inflammation (which is interrelated to insulin resistance, oxidative stress, wasting and endothelial dysfunction) has been suggested to be a significant contributor. Indeed, several different inflammatory biomarkers, such as high sensitivity C-reactive protein (CRP) has been shown to independently predict mortality in CKD patients. The causes of the highly prevalent state of inflammation in CKD are multiple and include factors such as volume overload, co-morbidity, intercurrent clinical events, the dialysis procedure per se as well as genetic factors. Indeed, multiple cytokine DNA polymorphisms may affect the inflammatory state, the clinical phenotype as well as outcome in this patient population.Keywords
This publication has 72 references indexed in Scilit:
- C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney diseaseKidney International, 2005
- CRP or not CRP? That Is the QuestionArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Cardiovascular Mortality Risk in Chronic Kidney DiseaseJAMA, 2005
- IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia—The good, the bad, and the uglyKidney International, 2005
- Septicemia in the United States Dialysis Population, 1991 to 1999Journal of the American Society of Nephrology, 2004
- Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patientsNephrology Dialysis Transplantation, 2004
- C-reactive protein and cardiovascular disease in peritoneal dialysis patientsKidney International, 2002
- The interleukin-10 promoter genotype determines clinical immune function in hemodialysis patientsKidney International, 2001
- Atherosclerotic cardiovascular disease risks in chronic hemodialysis patientsKidney International, 2000
- Inflammation enhances cardiovascular risk and mortality in hemodialysis patientsKidney International, 1999